DY
Dyadic International, Inc.
DYAI · NASDAQ
$0.40 -2.99% (-$0.01)
1M -44.01%
Market Cap $14.7M
P/E Ratio -
Div. Yield -
ROE 2,918.10%
Piotroski F-Score Weak
3/9Valuation
43 /100
Fair P/S 4.22x
P/FCF N/A
P/B N/A
Growth
0 /100
Declining Book val. growth 51.92%
Rev. growth 25.08%
FCF growth N/A
Profitability
11 /100
Weak FCF margin 213.22%
Op. margin 213.59%
Gross margin 30.44%
Quality
7 /100
Poor Asset turnover 0.53x
ROA 116.60%
ROIC 278.95%
Debt
36 /100
Moderate Int. coverage -17.20x
Current ratio 1.65x
Net debt/EBITDA N/A
Stability
42 /100
Moderate Profitable years 0
EPS volatility 22.87%
Beta 1.15x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about DYAI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Mark A. Emalfarb
Employees
5
Headquarters
Jupiter
Upcoming events
11 NOV
Earnings
Upcoming earnings report